Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET END USER COVERAGE GRID
2.8 PROCESS LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 POTERS FIVE FORCES
5 NORTH AMERICA MEDICINAL CHEMISTRY IN DRUG DISCOVERY MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASE IN R&D FOR DISCOVERY AND DEVELOPMENT OF NOVEL DRUG MOLECULES
6.1.2 RISE IN CHRONIC DISEASES
6.1.3 INITIATIVES FOR RESEARCH ON RARE DISEASES AND ORPHAN DRUGS
6.1.4 GROWTH IN BIOLOGICS
6.1.5 COLLABORATIONS AMONG RESEARCHERS AND PHARMACEUTICAL INDUSTRIES
6.2 RESTRAINTS
6.2.1 RISE IN COST OF FORMULATED DRUG
6.2.2 TECHNICAL RISKS IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY
6.2.3 BIOETHICAL ISSUES IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY
6.3 OPPORTUNITIES
6.3.1 ADVANCEMENTS IN BIOCHEMICAL, TRANSLATIONAL, AND MOLECULAR STUDIES
6.3.2 RISE IN HEALTHCARE EXPENDITURE
6.3.3 USE OF ARTIFICIAL INTELLIGENCE IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY
6.4 CHALLENGES
6.4.1 BIOLOGICS NEED SPECIALIST TESTING SERVICES
6.4.2 STRINGENT REGULATIONS
7 IMPACT OF COVID-19 ON NORTH AMERICA MEDICINAL CHEMISTRY IN DRUG DISCOVERY MARKET
7.1 IMPACT ON PRICE
7.2 IMPACT ON DEMAND
7.3 IMPACT ON SUPPLY CHAIN
7.4 STRATEGIC DECISIONS BY MANUFACTURERS
7.5 CONCLUSION
8 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS
8.1 OVERVIEW
8.2 TARGET SELECTION
8.3 TARGET VALIDATION
8.4 HIT-TO-LEAD IDENTIFICATION
8.5 LEAD OPTIMIZATION
8.6 CANDIDATE VALIDATION
9 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN
9.1 OVERVIEW
9.2 FRAGMENT-BASED VARIATION
9.3 STRUCTURE BASED DRUG DESIGN
9.4 DIVERSITY ORIENTED SYNTHESIS
9.5 CHEMOGENOMICS
9.6 NATURAL PRODUCTS
9.7 OTHERS
10 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE
10.1 OVERVIEW
10.2 SMALL MOLECULES
10.3 BIOLOGICS
11 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA
11.1 OVERVIEW
11.2 ONCOLOGY
11.3 NEUROLOGY
11.4 INFECTIOUS AND IMMUNE SYSTEM DISEASES
11.5 CARDIOVASCULAR DISEASES
11.6 DIGESTIVE SYSTEM DISEASES
11.7 OTHERS
12 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER
12.1 OVERVIEW
12.2 CONTRACT RESEARCH ORGANIZATION
12.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
12.4 ACADEMIC AND RESEARCH INSTITUTES
12.5 OTHERS
13 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY COUNTRY
13.1 OVERVIEW
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
14 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 EUROFINS SCIENTIFIC
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 SERVICE PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 LABCORP DRUG DEVELOPMENT
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 SERVICE PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 CHARLES RIVER
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 SERVICE PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 WUXI APPTEC
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 SERVICE PORTFOLIO
16.4.5 RECENT DEVELOPMENTS
16.5 EVOTEC SE
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 SERVICE PORTFOLIO
16.5.5 RECENT DEVELOPMENTS
16.6 THERMO FISHER SCIENTIFIC INC.
16.6.1 COMPANY SNAPSHOT
16.6.2 REVENUE ANALYSIS
16.6.3 SERVICE PORTFOLIO
16.6.4 RECENT DEVELOPMENT
16.6.4.1 ACQUISITION
16.7 AURIGENE PHARMACEUTICAL SERVICES (A SUBSIDIARY OF DR. REDDY'S LABORATORIES)
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 SERVICE PORTFOLIO
16.7.4 RECENT DEVELOPMENT
16.8 BIOBLOCKS INC
16.8.1 COMPANY SNAPSHOT
16.8.2 SERVICE PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 CERTARA INC
16.9.1 COMPANY SNAPSHOT
16.9.2 REVENUE ANALYSIS
16.9.3 SERVICE PORTFOLIO
16.9.4 RECENT DEVELOPMENTS
16.1 DRUG DISCOVERY ALLIANCES
16.10.1 COMPANY SNAPSHOT
16.10.2 SERVICE PORTFOLIO
16.10.3 RECENT DEVELOPMENT
16.11 GENSCRIPT BIOTECH
16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 SERVICE PORTFOLIO
16.11.4 RECENT DEVELOPMENT
16.12 JUBILANT BIOSYS
16.12.1 COMPANY SNAPSHOT
16.12.2 SERVICE PORTFOLIO
16.12.3 RECENT DEVELOPMENTS
16.13 NANOSYN
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 NEREID THERAPEUTICS
16.14.1 COMPANY SNAPSHOT
16.14.2 SERVICE PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 PFIZER INC.
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 SERVICE PORTFOLIO
16.15.4 RECENT DEVELOPMENTS
16.16 SELVITA
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 SERVICE PORTFOLIO
16.16.4 RECENT DEVELOPMENTS
16.16.4.1 ACQUISITION
16.17 SPECTRIS PLC
16.17.1 COMPANY SNAPSHOT
16.17.2 REVENUE ANALYSIS
16.17.3 SERVICE PORTFOLIO
16.17.4 RECENT DEVELOPMENT
16.18 SYGNATURE DISCOVERY
16.18.1 COMPANY SNAPSHOT
16.18.2 SERVICE PORTFOLIO
16.18.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
List of Table
TABLE 1 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)
TABLE 2 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 3 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 4 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
TABLE 5 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 6 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 7 U.S. MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)
TABLE 8 U.S. MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN 2020-2029 (USD MILLION)
TABLE 9 U.S. MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 10 U.S. MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
TABLE 11 U.S. MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 12 CANADA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)
TABLE 13 CANADA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 14 CANADA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 15 CANADA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
TABLE 16 CANADA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 17 MEXICO MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)
TABLE 18 MEXICO MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 19 MEXICO MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 20 MEXICO MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
TABLE 21 MEXICO MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)
List of Figure
FIGURE 1 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: DROC ANALYSIS
FIGURE 4 MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: END USER COVERAGE GRID
FIGURE 8 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: SEGMENTATION
FIGURE 11 GROWTH IN BIOLOGICS DISCOVERY AND COLLABORATION AMONG RESEARCHERS AND PHARMACEUTICAL INDUSTRY IS EXPECTED TO DRIVE THE NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 PROCESS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET
FIGURE 14 ESTIMATED NEW CANCER CASES IN 2021, IN THE U.S.
FIGURE 15 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY PROCESS, 2021
FIGURE 16 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY PROCESS, 2020-2029 (USD MILLION)
FIGURE 17 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY PROCESS, CAGR (2022-2029)
FIGURE 18 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY PROCESS, LIFELINE CURVE
FIGURE 19 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DESIGN, 2021
FIGURE 20 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DESIGN, 2020-2029 (USD MILLION)
FIGURE 21 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DESIGN, CAGR (2022-2029)
FIGURE 22 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DESIGN, LIFELINE CURVE
FIGURE 23 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DRUG TYPE, 2021
FIGURE 24 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DRUG TYPE, 2020-2029 (USD MILLION)
FIGURE 25 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DRUG TYPE, CAGR (2022-2029)
FIGURE 26 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DRUG TYPE, LIFELINE CURVE
FIGURE 27 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY THERAPEUTIC AREA, 2021
FIGURE 28 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
FIGURE 29 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY THERAPEUTIC AREA, CAGR (2022-2029)
FIGURE 30 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY THERAPEUTIC AREA, LIFELINE CURVE
FIGURE 31 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY END USER, 2021
FIGURE 32 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY END USER, 2020-2029 (USD MILLION)
FIGURE 33 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY END USER, CAGR (2022-2029)
FIGURE 34 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY END USER, LIFELINE CURVE
FIGURE 35 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: SNAPSHOT (2021)
FIGURE 36 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY COUNTRY (2021)
FIGURE 37 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY COUNTRY (2022 & 2029)
FIGURE 38 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 39 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY PROCESS (2022-2029)
FIGURE 40 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: COMPANY SHARE 2021 (%)
